AKERO THERAPEUTICS INC shareholders Q3 2023

AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 188 filers reported holding AKERO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.

AKERO THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Zurcher Kantonalbank (Zurich Cantonalbank) 9,878$499,6290.00%
ProShare Advisors LLC 10,303$521,1260.00%
VOYA INVESTMENT MANAGEMENT LLC 33,611$1,700,0440.00%
CREDIT SUISSE AG/ 43,195$2,184,8040.00%
MORGAN STANLEY 439,736$22,241,8470.00%
SEI INVESTMENTS CO 18,908$956,3670.00%
DIMENSIONAL FUND ADVISORS LP 102,420$5,178,0240.00%
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM 14,650$740,9970.00%
Nuveen Asset Management, LLC 131,483$6,650,4100.00%
Tower Research Capital LLC (TRC) 1,046$52,9070.00%
FARALLON CAPITAL MANAGEMENT LLC 4,000$202,3200.00%
UBS ASSET MANAGEMENT AMERICAS LLC 46,539$2,353,9440.00%
Walleye Trading LLC 7,400$374,2920.00%
MACQUARIE GROUP LTD 22,785$1,152,0000.00%
Citadel Advisors 51,000$2,579,5800.00%
MILLENNIUM MANAGEMENT LLC 36,200$1,830,9960.00%
Legal & General Group Plc 43,249$2,187,5340.00%
WELLS FARGO & COMPANY/MN 45,606$2,306,7510.00%
BANK OF AMERICA CORP /DE/ 194,885$9,857,2830.00%
GTS SECURITIES LLC 15,986$808,5720.00%
External links

This page lists AKERO THERAPEUTICS INC's shareholders in Q3 2023. To view AKERO THERAPEUTICS INC's shareholder history, click here.